(19)
(11) EP 2 480 573 A1

(12)

(43) Date of publication:
01.08.2012 Bulletin 2012/31

(21) Application number: 10754524.6

(22) Date of filing: 20.09.2010
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
C12Q 1/68(2006.01)
A61P 35/00(2006.01)
C12N 15/11(2006.01)
G01N 33/50(2006.01)
A61P 35/04(2006.01)
(86) International application number:
PCT/EP2010/063802
(87) International publication number:
WO 2011/036118 (31.03.2011 Gazette 2011/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 22.09.2009 EP 09170932

(71) Applicant: Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research
4058 Basel (CH)

(72) Inventors:
  • CIOSK, Rafal
    CH-4125 Riehen (CH)
  • KALCHHAUSER, Irène
    CH-4053 Basel (CH)

(74) Representative: Favre, Nicolas 
Novartis Pharma AG Patent Department
4002 Basel
4002 Basel (CH)

   


(54) TREATING CANCER BY MODULATING MEX-3